These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9832968)

  • 21. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
    Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
    Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze.
    Rodgers RJ; Nikulina EM; Cole JC
    Pharmacol Biochem Behav; 1994 Dec; 49(4):985-95. PubMed ID: 7886117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task.
    Ennaceur A; Michalikova S; van Rensburg R; Chazot PL
    Behav Brain Res; 2008 Mar; 188(1):136-53. PubMed ID: 18055029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a hydroethanolic extract of Boophone disticha bulb on anxiety-related behaviour in naive BALB/c mice.
    Pote W; Musarira S; Chuma D; Gadaga LL; Mwandiringana E; Tagwireyi D
    J Ethnopharmacol; 2018 Mar; 214():218-224. PubMed ID: 29223391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploratory behavior models of anxiety in mice.
    Crawley JN
    Neurosci Biobehav Rev; 1985; 9(1):37-44. PubMed ID: 2858080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice.
    Belzung C; Le Guisquet AM; Crestani F
    Psychopharmacology (Berl); 2000 Jan; 148(1):24-32. PubMed ID: 10663414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice.
    Reddy DS; Kulkarni SK
    Brain Res; 1997 Mar; 752(1-2):61-71. PubMed ID: 9106441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat.
    Merlo Pich E; Samanin R
    Pharmacol Res; 1989; 21(5):595-602. PubMed ID: 2574443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.
    Kliethermes CL; Finn DA; Crabbe JC
    Psychopharmacology (Berl); 2003 Sep; 169(2):190-7. PubMed ID: 12783153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.
    Prut L; Belzung C
    Eur J Pharmacol; 2003 Feb; 463(1-3):3-33. PubMed ID: 12600700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Anxiolytic" action of diazepam and abecarnil in a modified open field test.
    Rex A; Stephens DN; Fink H
    Pharmacol Biochem Behav; 1996 Apr; 53(4):1005-11. PubMed ID: 8801571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test.
    Ago Y; Takahashi K; Nakamura S; Hashimoto H; Baba A; Matsuda T
    J Pharmacol Sci; 2007 Jun; 104(2):153-8. PubMed ID: 17538228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ambivalent behaviour "stretched approach posture" in the rat as a paradigm to characterize anxiolytic drugs.
    Molewijk HE; van der Poel AM; Olivier B
    Psychopharmacology (Berl); 1995 Sep; 121(1):81-90. PubMed ID: 8539344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytic-like effect of nafadotride and PNU 99194A, dopamine D3 receptor antagonists in animal models.
    Rogóz Z; Kłodzińska A; Maj J
    Pol J Pharmacol; 2000; 52(6):459-62. PubMed ID: 11334239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic-like effects and toxicological studies of Brickellia cavanillesii (Cass.) A. Gray in experimental mice models.
    Ávila-Villarreal G; González-Trujano ME; Carballo-Villalobos AI; Aguilar-Guadarrama B; García-Jiménez S; Giles-Rivas DE; Castillo-España P; Villalobos-Molina R; Estrada-Soto S
    J Ethnopharmacol; 2016 Nov; 192():90-98. PubMed ID: 27381041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral effects of alpha 2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice.
    Durcan MJ; Lister RG; Linnoila M
    Psychopharmacology (Berl); 1989; 97(2):189-93. PubMed ID: 2567025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of cage leaving behaviour in rats as a free choice paradigm.
    Bert B; Schmidt N; Voigt JP; Fink H; Rex A
    J Pharmacol Toxicol Methods; 2013; 68(2):240-249. PubMed ID: 23313807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors.
    Chopin P; Pellow S; File SE
    Neuropharmacology; 1986 Jan; 25(1):53-7. PubMed ID: 2869438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.
    Hendrie CA; Neill JC; Shepherd JK; Dourish CT
    Physiol Behav; 1993 Oct; 54(4):689-93. PubMed ID: 7902586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the cholecystokinin system in anxiolytic activity of dipeptide GB-115.
    Kolik LG; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2012 Oct; 153(6):851-4. PubMed ID: 23113301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.